Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kymera Therapeutics Inc.

    NASDAQ: KYMR · Real-Time Price · USD
    42.62
    1.07 (2.58%)
    At close: Aug 15, 2025, 3:59 PM
    43.44
    1.92%
    After-hours: Aug 15, 2025, 05:03 PM EDT

    Kymera Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -223.86M -146.96M -154.81M -100.22M
    Depreciation & Amortization
    		 7.37M 3.56M 2.98M 2.4M
    Stock-Based Compensation
    		 55.01M 43.12M 35.48M 24.97M
    Other Working Capital
    		 -41.48M -7.73M -37.88M -71.26M
    Other Non-Cash Items
    		 -9.06M -5.23M 889K 5.83M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -23.97M 2.68M -37.62M -61.92M
    Operating Cash Flow
    		 -194.5M -102.83M -153.09M -128.95M
    Capital Expenditures
    		 -12.84M -34.48M -2.84M -1.6M
    Cash Acquisitions
    		 n/a n/a -20.52M 5.81M
    Purchase of Investments
    		 -901.23M -189.15M -445.97M -456.4M
    Sales Maturities Of Investments
    		 496M 363.52M 469.33M 358.17M
    Other Investing Acitivies
    		 13.98M n/a 20.52M -5.81M
    Investing Cash Flow
    		 -404.08M 139.89M 20.52M -99.83M
    Debt Repayment
    		 -1.58M -76K -1.13M -849K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 13.81M 4.27M 4.3M 8.02M
    Financial Cash Flow
    		 608.85M 4.19M 153M 250.28M
    Net Cash Flow
    		 10.27M 41.25M 20.43M 21.5M
    Free Cash Flow
    		 -207.34M -137.31M -155.92M -130.54M

    Add to Watchlist